JFG
VRTX icon

Jefferies Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Jefferies Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6M Sell
23,810
-7,562
-24% -$3.53M 0.07% 199
2025
Q4 		$14.2M Buy
31,372
+15,372
+96% +$6.63M 0.07% 258
2025
Q3 		$6.27M Sell
16,000
-18,615
-54% -$7.78M 0.03% 310
2025
Q2 		$15.4M Buy
34,615
+15,131
+78% +$6.97M 0.13% 120
2025
Q1 		$9.45M Buy
19,484
+5,500
+39% +$2.56M 0.08% 165
2024
Q4 		$5.63M Sell
13,984
-18,659
-57% -$8.65M 0.03% 337
2024
Q3 		$15.2M Sell
32,643
-27,632
-46% -$13.3M 0.11% 119
2024
Q2 		$28.3M Buy
60,275
+3,453
+6% +$1.5M 0.3% 53
2024
Q1 		$23.8M Buy
56,822
+38,814
+216% +$16.4M 0.22% 70
2023
Q4 		$7.33M Buy
18,008
+17,707
+5,883% +$6.54M 0.05% 301
2023
Q3 		$105K Sell
301
-10,632
-97% -$3.72M ﹤0.01% 1449
2023
Q2 		$3.85M Sell
10,933
-191
-2% -$64.4K 0.03% 421
2023
Q1 		$3.5M Buy
11,124
+3,636
+49% +$1.09M 0.03% 469
2022
Q4 		$2.16M Buy
+7,488
New +$2.28M 0.02% 629
2016
Q2 		– Sell
-3,300
Closed -$262K – 71
2016
Q1 		$262K Buy
+3,300
New +$298K 0.04% 30

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Jefferies Financial Group's VRTX Position: Q1 2026 in Review

Jefferies Financial Group reduced its Vertex Pharmaceuticals (VRTX) stake by 24% in Q1 2026, selling an estimated $3.53M and leaving 23,810 shares worth $10.6M. The position accounts for 0.07% of the portfolio, ranked #199.

Jefferies Financial Group first reported a position in VRTX in Q1 2016 and has held it in 15 quarters since. The position peaked at $28.3M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Jefferies Financial Group held 23,810 shares of Vertex Pharmaceuticals worth $10.6M as of Q1 2026.
  • Jefferies Financial Group sold 7,562 Vertex Pharmaceuticals shares in Q1 2026, an estimated $3.53M.
  • Vertex Pharmaceuticals made up 0.07% of Jefferies Financial Group's portfolio in Q1 2026, its #199 holding.
  • Jefferies Financial Group first reported a position in Vertex Pharmaceuticals in Q1 2016 and has held it in 15 quarters since.
  • Jefferies Financial Group's Vertex Pharmaceuticals position peaked at $28.3M in Q2 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.